Andrii Zaremba

4PUBLICATIONS
2CO-AUTHORS
Biologically active moleculesEpigenetics (incl. genome methylation and epigenomics)Biomolecular modelling and designMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 07, 2026
Ketodarolutamide may interact with the receptor-binding domain of the SARS-CoV-2 spike glycoprotein: the importance of halogenated benzonitrile.

|Apr 03, 2023
In silico study of HASDI (high-affinity selective DNA intercalator) as a new agent capable of highly selective recognition of the DNA sequence.

Andrii A Zaremba, Polina Yu Zaremba, Svitlana D Zahorodnia

|Nov 01, 2022
De novo designed inhibitor has high affinity to four variants of the RBD of S-glycoprotein of SARS-CoV-2 - an in silico study.

Andrii Zaremba, Polina Zaremba, Svіtlana Zahorodnia

|Mar 22, 2022
De novo designed EBAI as a potential inhibitor of the viral protein BHRF1. Research in silico.

Andrii A Zaremba, Polina Y Zaremba, Maxim O Platonov

Pageof 1

Frequent Collaborators

3 joint publications

Polina Zaremba

3 joint publications

Svіtlana Zahorodnia